The PLD-P700 resulted in great enhancement in cellular uptake and cytotoxicity in different cell lines, including mouse (4T1) and human (MCF-7) breast cancer cells and mouse endothelial cell line (H5V) compared to non-modified PLD [36]. The gene discussed is GPLD1; the disease is breast cancer.